Leonard Bell, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 1,050 shares at $180.10 ($189K) on 2015-09-09, disclosed to the SEC on 2015-09-10.
Scheduled sale ($189k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| ALXN | SELL | 2017-02-08 | $2.2M | — | Filing → |
| ALXN | SELL | 2017-01-13 | $14K | — | Filing → |
| ALXN | SELL | 2017-01-09 | $5.5M | — | Filing → |